The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Infectious Disease Diagnostics Testing Market Between 2026 And 2030?
The infectious disease diagnostics testing market size has experienced significant expansion recently. This market is projected to expand from $42.24 billion in 2025 to $46.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.0%. Historically, this growth has been driven by factors such as the increasing prevalence of infectious diseases, a rise in respiratory infection cases, the expanding infrastructure of diagnostic laboratories, heightened awareness regarding early disease diagnosis, and a greater government emphasis on disease control.
The market for infectious disease diagnostics testing is projected to experience robust expansion over the coming years. It is anticipated to reach a valuation of $65.49 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period is attributable to several factors, including the escalating risk of global pandemics, the increasing need for prompt diagnostic solutions, greater investments in healthcare diagnostics, the expansion of disease surveillance initiatives, and the increasing prevalence of tropical and viral diseases. Key trends shaping the forecast period encompass a growing requirement for swift and early detection of infectious diseases, the increasing uptake of point-of-care infectious disease tests, a rise in the application of molecular diagnostics for identifying pathogens, the broadening of diagnostic testing for both emerging and re-emerging infections, and an intensified emphasis on large-scale disease screening and surveillance.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp
What Major Drivers Are Influencing Demand In The Infectious Disease Diagnostics Testing Market?
An expected increase in respiratory infections is poised to drive the growth of the infectious disease diagnostic testing market in the future. These infections impact the respiratory system, including the nose, throat, airways, and lungs. The escalating respiratory infections are a result of viral and bacterial transmission through close contact with infected individuals, insufficient hygiene practices, densely populated living spaces, and seasonal changes in weather patterns. Infectious disease diagnostic testing is crucial for both diagnosing and treating respiratory infections, as it allows for the precise identification of pathogens such as bacteria and viruses in patient samples. For instance, in February 2024, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, hospitalizations for acute upper respiratory infections saw an increase of 32% from 2,114 cases in 2022 to 2,797 cases in 2023. Therefore, the rise in respiratory infections is a key driver for the infectious disease diagnostic testing market.
Which Market Segments Are Examined In The Infectious Disease Diagnostics Testing Market Study?
The infectious disease diagnostics testing market covered in this report is segmented –
1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics
Subsegments:
1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs)
2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR
Which Trends Are Influencing The Infectious Disease Diagnostics Testing Market?
Leading companies in the infectious disease diagnostic testing market are developing innovative technologies to quickly and reliably identify critical infections. Infectious disease diagnostics involves pinpointing pathogens, such as bacteria, viruses, or parasites, to inform diagnosis and treatment strategies. For instance, in January 2025, QIAGEN, a Germany-based biotechnology firm, introduced new QIAstat-Dx syndromic testing panels in India, including the Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel. These were launched alongside the previously authorized Respiratory SARS-CoV-2 Panel, all having received approval from India’s Central Drugs Standard Control Organization (CDSCO). The QIAstat-Dx system utilizes multiplex real-time PCR with single-use cartridges to detect multiple pathogens simultaneously, providing results in approximately an hour for gastrointestinal infections and 80 minutes for central nervous system infections. These panels improve diagnostic speed and accuracy when compared to traditional methods, thus enabling timely treatment, enhancing patient outcomes, and reducing the workload on healthcare systems. The system additionally offers configurable setups and cloud connectivity for remote monitoring and streamlined data management.
Who Are The Primary Competitors In The Infectious Disease Diagnostics Testing Market?
Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC
Read the full infectious disease diagnostics testing market report here:
Which Region Shows The Strongest Potential For Future Growth In The Infectious Disease Diagnostics Testing Market?
North America was the largest region in the infectious disease diagnostics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Infectious Disease Diagnostics Testing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp
Browse Through More Reports Similar to the Global Infectious Disease Diagnostics Testing Market 2026, By The Business Research Company
Disposable Incontinence Products Market Report 2026
Urinary Incontinence Market Report 2026
https://www.thebusinessresearchcompany.com/report/urinary-incontinence-global-market-report
Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model